- today
Growth hormone releasing peptide 2 or GHRP 2 is a synthetic analogue of GHRP 6. It is well-known for its ability to effectively improve and stimulate the production of human growth hormone. It also plays a role as a ghrelin activator. Ghrelin is a newly discovered peptide found in the gut. It binds to growth hormone secretagogue receptors as well as promotes food and stomach emptying.
GHRP 2 is a potent hexapeptide similar to GHRP 6. It has been extensively studied for its ability as a GHS (growth hormone secretagogue) or to stimulate the production of growth hormones. It is popular for its capacity to stimulate the release of ghrelin resulting in increased appetite and hunger. This peptide is best used to correct decreased production of growth hormones. It is also able to help unusually lean individuals gain weight. It is also an excellent substance to reverse the effects of ageing amongst persons with low growth hormone levels.
How does GHRP 2 work?
GHRP 2 works by stimulating the pituitary gland’s natural ability to produce endogenous human growth hormone (HGH). It enhances HGH production in two ways – first, it amplifies the transduction pathway of natural growth hormone releasing signal which leads to an increase in growth hormone levels. Second, it inhibits the activities of somatostatin thus bringing about an increase in endogenous growth hormone levels.
Warning
THE GOODS OFFERED BY THE SELLER IS INTENDED FOR SCIENTIFIC AND DEVELOPMENT PURPOSES ONLY. The goods offered by the Seller include chemical substances that shall not be used as a drug, medicine, active substance, medical aid, cosmetic product, a substance for production of a cosmetic product neither for human consumption that is any food or food supplement or otherwise similarly used on humans or animals.
References / Links
- Bowers, C. Y., Reynolds, G. A., Durham, D., Barrera, C. M., Pezzoli, S. S., & Thorner, M. O. (1990). Growth hormone (GH)-releasing peptide stimulates GH release in normal men and acts synergistically with GH-releasing hormone. Journal of Clinical Endocrinology & Metabolism, 70(4), 975–982. PubMed
- Bowers, C. Y. (1993). Growth hormone-releasing peptides. Annals of the New York Academy of Sciences, 692(1), 10–21. PubMed
- Arvat, E., Gianotti, L., Ramunni, J., Maccagno, B., Camanni, F., & Ghigo, E. (1997). Mechanisms underlying the positive synergistic interaction between growth hormone-releasing hormone and hexarelin, a synthetic hexapeptide, in humans. Journal of Clinical Endocrinology & Metabolism, 82(2), 341–345. PubMed
- Arvat, E., Di Vito, L., Broglio, F., Papotti, M., Muccioli, G., Dieguez, C., Casanueva, F. F., Deghenghi, R., Camanni, F., & Ghigo, E. (2000). Preliminary evidence that Ghrelin, the natural GH secretagogue (GHS)-receptor ligand, strongly stimulates GH secretion in humans. Journal of Clinical Endocrinology & Metabolism, 85(12), 4908–4911. PubMed
- Smith, R. G., Van der Ploeg, L. H. T., Howard, A. D., Feighner, S. D., Cheng, K., Hickey, G. J., Wyvratt, M. J., & Fisher, M. H. (1997). Peptidomimetic regulation of growth hormone secretion. Endocrine Reviews, 18(5), 621–645. PubMed
Research Quality Begins with Peptide Quality
At Particle Peptides, we believe that reliable research begins with reliable materials. That is why our research peptides are manufactured on cGMP-compliant production lines by a global pharmaceutical CDMO, and every batch undergoes independent third-party testing for:
- Purity
- Identity confirmation
- Peptide content
- Endotoxin levels
- Heavy metals (Class I & II)
- Microbial contamination (TAMC & TYMC)
Transparency and independently verified laboratory data form the foundation of high-quality scientific research.
Disclaimer: All Particle Peptides products are intended exclusively for scientific research and laboratory use. They are not intended for human or veterinary use, nor for the diagnosis, treatment, cure, or prevention of any disease.
